Literature DB >> 27810600

Chemical exploration of 4-(4-fluorobenzyl)piperidine fragment for the development of new tyrosinase inhibitors.

Stefania Ferro1, Laura De Luca2, Maria Paola Germanò2, Maria Rosa Buemi2, Laura Ielo2, Giovanna Certo3, Margarita Kanteev4, Ayelet Fishman4, Antonio Rapisarda2, Rosaria Gitto2.   

Abstract

Tyrosinase is involved in the production of melanin through the hydroxylation of monophenols to o-diphenols. The role of this enzyme was extensively studied in order to identify new therapeutics preventing skin pigmentation and melanoma. In this work we initially identified the 3-(4-benzylpiperidin-1-yl)-1-(1H-indol-3-yl)propan-1-one (1a) as promising mushroom tyrosinase inhibitor (IC50 = 252 μM). Then, several chemical modifications were performed and new analogues related to compound 1a were synthesized. Biochemical assays demonstrated that several obtained compounds proved to be effective inhibitors showing IC50 values lower both than "lead compound" 1a and reference inhibitor kojic acid, as a well-known tyrosinase inhibitor. The inhibition kinetics analyzed by Lineweaver-Burk plots revealed that compounds 2 a-c and 10b act as non-competitive inhibitors while the most active inhibitor 2d (IC50 = 7.56 μM) is a mixed-type inhibitor. Furthermore, experimental and computational structural studies were performed in order to clarify the binding mode of the derivative 2d. Copyright Â
© 2016 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Crystallography; Docking studies; Kinetic mechanism; SARs; Synthesis; Tyrosinase inhibitors

Mesh:

Substances:

Year:  2016        PMID: 27810600     DOI: 10.1016/j.ejmech.2016.10.030

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  7 in total

1.  Indole-Containing Amidinohydrazones as Nonpeptide, Dual RXFP3/4 Agonists: Synthesis, Structure-Activity Relationship, and Molecular Modeling Studies.

Authors:  Dongliang Guan; Md Toufiqur Rahman; Elaine A Gay; Vineetha Vasukuttan; Kelly M Mathews; Ann M Decker; Alexander H Williams; Chang-Guo Zhan; Chunyang Jin
Journal:  J Med Chem       Date:  2021-12-02       Impact factor: 7.446

Review 2.  A comprehensive review on tyrosinase inhibitors.

Authors:  Samaneh Zolghadri; Asieh Bahrami; Mahmud Tareq Hassan Khan; J Munoz-Munoz; F Garcia-Molina; F Garcia-Canovas; Ali Akbar Saboury
Journal:  J Enzyme Inhib Med Chem       Date:  2019-12       Impact factor: 5.051

Review 3.  Melanins as Sustainable Resources for Advanced Biotechnological Applications.

Authors:  Hanaa A Galeb; Emma L Wilkinson; Alison F Stowell; Hungyen Lin; Samuel T Murphy; Pierre L Martin-Hirsch; Richard L Mort; Adam M Taylor; John G Hardy
Journal:  Glob Chall       Date:  2020-11-25

4.  The antityrosinase and antioxidant activities of flavonoids dominated by the number and location of phenolic hydroxyl groups.

Authors:  Ai-Ren Zuo; Huan-Huan Dong; Yan-Ying Yu; Qing-Long Shu; Li-Xiang Zheng; Xiong-Ying Yu; Shu-Wen Cao
Journal:  Chin Med       Date:  2018-10-19       Impact factor: 5.455

5.  Identification by shape-based virtual screening and evaluation of new tyrosinase inhibitors.

Authors:  Qi Li; Hongyu Yang; Jun Mo; Yao Chen; Yue Wu; Chen Kang; Yuan Sun; Haopeng Sun
Journal:  PeerJ       Date:  2018-01-26       Impact factor: 2.984

6.  Structural Optimization and Improving Antitumor Potential of Moreollic Acid from Gamboge.

Authors:  Li-Zhi Cheng; Dan-Ling Huang; Min Liao; Ke-Ming Li; Zhao-Qiu Wu; Yong-Xian Cheng
Journal:  Molecules       Date:  2022-01-13       Impact factor: 4.411

7.  Evaluation of 4-(4-Fluorobenzyl)piperazin-1-yl]-Based Compounds as Competitive Tyrosinase Inhibitors Endowed with Antimelanogenic Effects.

Authors:  Salvatore Mirabile; Serena Vittorio; Maria Paola Germanò; Ilenia Adornato; Laura Ielo; Antonio Rapisarda; Rosaria Gitto; Francesca Pintus; Antonella Fais; Laura De Luca
Journal:  ChemMedChem       Date:  2021-07-26       Impact factor: 3.466

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.